Rigel Pharmaceuticals RIGL Accounts Payable
Accounts Payable at other companies
Other financials
Where this comes from
Reported directly by Rigel Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:AccountsPayableCurrent.
The official record: Rigel Pharmaceuticals’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →
Ask your AI about Rigel Pharmaceuticals's accounts payable.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Rigel Pharmaceuticals's accounts payable?
- Rigel Pharmaceuticals (RIGL) reported accounts payable of $4.49M in Q1 2026.
- How has Rigel Pharmaceuticals's accounts payable changed year-over-year?
- Rigel Pharmaceuticals's accounts payable increased by 13.5% year-over-year, from $3.95M to $4.49M.
- What is the long-term trend for Rigel Pharmaceuticals's accounts payable?
- Over 5 years (2020 to 2025), Rigel Pharmaceuticals's accounts payable has grown at a 14.2% compound annual growth rate (CAGR), from $3.71M to $7.19M.
- What does accounts payable mean?
- Amounts owed to suppliers and vendors for goods and services received but not yet paid. A primary source of short-term trade financing.